Skip to main content

RAFFLES ASSOCIATES LP

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1169581 NEW YORK, NY

Position in LCTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,473,205
-$482,650 QoQ
Shares Held
5,362,788
0.0% QoQ
Ownership
2.15%
of shares outstanding
% of Portfolio
8.44%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RAFFLES ASSOCIATES LP holds $8,473,205 across 1 Biotechnology name. LCTX ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LCTX
Lineage Cell Therapeutics, Inc.
This page
5,362,788 $8,473,205

All Filings in LCTX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,473,205 5,362,788
2025-12-31 $8,955,855 5,362,788
2025-09-30 $9,105,361 5,387,788
2025-06-30 $4,906,800 5,392,088
2025-03-31 $2,538,939 5,642,088
2024-12-31 $2,746,044 5,492,088
2024-09-30 $4,102,080 4,507,781
2024-06-30 $4,357,781 4,357,781
2024-03-31 $4,750,771 3,209,981
2023-12-31 $2,323,466 2,131,621
2023-09-30 $1,873,532 1,587,739
2023-06-30 $2,252,811 1,597,739
2023-03-31 $2,305,419 1,536,946
2022-12-31 $1,798,226 1,536,946
2022-09-30 $2,351,005 2,080,536
2022-06-30 $3,050,246 1,930,536
2022-03-31 $2,011,386 1,306,095
2021-12-31 $1,331,795 543,590
2021-09-30 $235,846 93,590
2021-06-30 $124,231 43,590
2021-03-31 $102,436 43,590